Ali A Habib

Ali A. Habib, MD is a Professor in the Department of Neurology at the University of California, Irvine (UCI) School of Medicine. He serves as Program Director for both the Neuromuscular Medicine Fellowship and Advanced Neuromuscular Medicine Fellowship within the Neurology department. His research focuses on myasthenia gravis (MG) and the development of patient-reported outcome measures to assess disease severity.

• Affiliation: UCI School of Medicine, Department of Neurology
• Role: Professor, Fellowship Program Director

Dr. Habib's work centers on clinical trials for MG, particularly evaluating therapies like rozanolixizumab and ravulizumab. He investigates muscle weakness fatigability, physical fatigue, and ocular/bulbar/respiratory muscle manifestations, emphasizing the need for modular outcome instruments that capture disease heterogeneity.

His research has been funded by collaborations with pharmaceutical companies including argenx, Alexion, and UCB Pharma. He contributes to refining severity continua for MG, distinguishing patterns like low-severity fatigue versus high-severity bulbar weakness, while advocating for further studies on ocular symptom specificity.